Study of SHP620 (Maribavir) in Healthy Adults

NCT02775240 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Cytomegalovirus (CMV)

Interventions

DRUG: Digoxin
DRUG: Maribavir
DRUG: Dextromethorphan

Sponsor

Shire